Cell Biology – Immunology – Pathology

Kidney International (2005) 68, 1078–1085; doi:10.1111/j.1523-1755.2005.00500.x

Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN1

YOSHIHARU NISHITANI, MASAYUKI IWANO, YUKINARI YAMAGUCHI, KOJI HARADA, KIMIHIKO NAKATANI, YASUHIRO AKAI, TOSHIHIKO NISHINO, HIDEO SHIIKI, MASAO KANAUCHI, YOSHIHIKO SAITO and ERIC G NEILSON

First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan; Department of Medicine, Vanderbilt University School of Medicine Nashville, Tennessee; and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee

Correspondence: Eric G. Neilson, Departments of Medicine and Cell and Developmental Biology, Vanderbilt University School of Medicine, 1161 Twenty-First Avenue South, Nashville, TN 37232-2358. E-mail: eric.neilson@vanderbilt.edu

1See Editorial by Bruneval, p. 1366.

Received 31 July 2004; Revised 18 February 2005; Accepted 19 April 2005.

Top

Abstract

Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN.

Background

 

There is little direct evidence that fibroblasts are involved in the progression of the renal interstitial fibrosis in human glomerulonephritis. With the availability of a new specific marker for fibroblasts, we determined the presence of fibroblasts in kidneys with IgA nephropathy (IgAN) and correlated their numbers with various clinical parameters. In particular, we also prospectively asked if the number of fibroblasts in the renal interstitium correlates with prognosis.

Methods

 

Cells positive for fibroblast-specific protein 1 (FSP1) were localized in renal biopsy specimens using immunohistochemistry with anti-FSP1 antibody. Clinical features were analyzed by one-way analysis of variance (ANOVA) with the Bonferroni correction. To assess the prognostic impact of the number of FSP1+ fibroblasts on renal survival in 142 patients with normal serum creatinine, the relationship between covariates to renal survival were evaluated univariately using the log-rank test and multivariately using Cox proportional hazards.

Results

 

Fibroblasts identified by their expression of FSP1 accumulate in areas showing severe interstitial fibrosis. Some tubular epithelial cells undergoing epithelial-mesenchymal transition (EMT) in fibrotic areas also express FSP1. Numbers of FSP1+ fibroblasts directly correlate with serum creatinine (r = 0.74, P < 0.0001) and inversely correlate with estimated creatinine clearance (r = -0.54, P < 0.0001), and by multivariate analysis, the clinical factors influencing renal survival are urinary protein excretion [greater than or equal to1.0 g/day, relative risk (RR) = 4.20, P = 0.032], hypertension (RR 5.85, P = 0.0027), and greater than or equal to20 FSP1+ fibroblasts per high power field (HPF) (RR 7.39, P = 0.0015). Staining for FSP1+ fibroblasts is largely nonoverlapping with alpha-smooth muscle actin+ (alpha-SMA) cells in the interstitium.

Conclusion

 

The target protein FSP1 identifies human fibroblasts and tubular epithelium undergoing EMT, and distinguishes them from the diaspora of alpha-SMA+ vascular smooth muscle cells. FSP1+ fibroblasts are critically related to the progression of IgAN; consequently, staining FSP1 in renal biopsy specimens provides a valuable histologic index of progression.

Keywords:

fibroblast-specific protein 1, IgA nephropathy, interstitial fibrosis, epithelial-mesenchymal transition, renal failure, and multivariate analysis

Extra navigation

.
ADVERTISEMENT